To determine other possible pathways regulating B7-H4 expression in tumor cells, we utilized published data from the I-SPY2 neoadjuvant clinical trial of early-stage breast cancer at high risk of recurrence (NCT01042379) that were assayed with RPPA from laser-capture microdissected tumor regions (43, 18). This evidence concerns the gene VTCN1 and breast carcinoma.